{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:45:06Z","timestamp":1776386706748,"version":"3.51.2"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2017-0358_s_999_w2aab3b7c13b1b6b1aab1c16b1Aa\">\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>Similar autoimmune processes (defective T-cell function) take place during the pathogenesis of aplastic anemia (AA) and Graves\u2019 disease (GD). Antithyroid drugs used for the management of GD may induce AA and GD may occur following treatment of severe aplastic anemia (SAA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2017-0358_s_998_w2aab3b7c13b1b6b1aab1c16b2Aa\">\n                  <jats:title>Case presentation:<\/jats:title>\n                  <jats:p>Clinical and laboratory investigations were performed for an 11-year-and-2-month-old girl who was referred for bilateral exophthalmus and abnormal thyroid function tests. She had been diagnosed as having severe acquired AA at the age of 8 years and had been treated with allogenic hematopoietic stem cell transplantation from her healthy human leukocyte antigen-matched sibling donor. Clinical examination revealed a weight of 32.6 kg (\u22120.88 standard deviation [SD] score); height, 145.7 cm (\u22120.14 SD score); body mass index 15.5 kg\/m<jats:sup>2<\/jats:sup> (\u22121.01 SD score); heart rate, 110\/min; blood pressure, 128\/74 mmHg; bilateral exophthalmos and an enlarged thyroid gland. The laboratory workup showed hemoglobin of 11.1 g\/dL; white blood cells, 7500\/mL; platelets, 172,000\/mL; free thyroxine (FT4), 4.80 ng\/dL (normal, 0.5\u20131.51); free triiodothyronine (FT3), 17.7 pg\/mL (normal, 2.5\u20133.9); thyrotropin (TSH), 0.015 mIU\/mL (normal, 0.38\u20135.3); antithyroglobulin peroxidase (TPO) antibody, 61.7 IU\/mL (normal, 0\u20139); antithyroglobulin (TG) antibody, &lt;0.9 IU\/mL (normal, 0\u20134) and thyrotropin (TSH) receptor antibodies 14 U\/L (normal, 0\u20131). Doppler ultrasonography showed diffuse enlargement of the thyroid gland and increased vascularity. She was treated with methimazole (0.6 mg\/kg\/day). L-thyroxine treatment was also needed (50 \u03bcg\/day). Thrombocytopenia developed during follow-up. A thyroidectomy was performed for definitive treatment at the 14th month of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2017-0358_s_997_w2aab3b7c13b1b6b1aab1c16b3Aa\">\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>The association of hyperthyroidism and AA in the pediatric age group is rare. The long-term use of antithyroid drugs and radioactive iodine should be avoided due to their hematologic toxic side effects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2017-0358","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T03:10:17Z","timestamp":1525144217000},"page":"589-593","source":"Crossref","is-referenced-by-count":8,"title":["Graves\u2019 disease following allogenic hematopoietic stem cell transplantation for severe aplastic anemia: case report and literature review"],"prefix":"10.1515","volume":"31","author":[{"given":"Ahu","family":"Paket\u00e7i","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korcan","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"T\u00fcfek\u00e7i","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezer","family":"Acar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Abac\u0131","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eebnem","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"B\u00f6ber","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology , Dokuz Eylul University, Faculty of Medicine , Izmir , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"key":"2021021322190482384_j_jpem-2017-0358_ref_001_w2aab3b7c13b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Williamson S, Greene SA. Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland. Clin Endocrinol 2010;72:358\u201363.","DOI":"10.1111\/j.1365-2265.2009.03717.x"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_002_w2aab3b7c13b1b6b1ab2b1b2Aa","unstructured":"Brown RS. The thyroid. In: Brook CGD, Clayton PE, Brown RS, editors. Brook\u2019s clinical pediatric endocrinology. London: Wiley-Blackwell, 2009:250\u201382."},{"key":"2021021322190482384_j_jpem-2017-0358_ref_003_w2aab3b7c13b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Jevalikar G, Solis J, Zacharin M. Long-term outcomes of pediatric Graves\u2019 disease. J Pediatr Endocrinol Metab 2014;27:1131\u20136.","DOI":"10.1515\/jpem-2013-0342"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_004_w2aab3b7c13b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108:2509\u201319.","DOI":"10.1182\/blood-2006-03-010777"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_005_w2aab3b7c13b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Hirano N, Butler MO, Von Bergwelt-Baildon MS, Maecker B, Schultze JL, et al. Autoantibodies frequently detected in patients with aplastic anemia. Blood 2003;102:4567\u201375.","DOI":"10.1182\/blood-2002-11-3409"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_006_w2aab3b7c13b1b6b1ab2b1b6Aa","unstructured":"Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, Oski FA, editors. Nathan and Oski\u2019s hematology of infancy and childhood. Philadelphia, PA: Saunders, 1998:237\u2013335."},{"key":"2021021322190482384_j_jpem-2017-0358_ref_007_w2aab3b7c13b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Bacigalupo A. How I treat acquired aplastic anemia. Blood 2017;129:1428\u201336.","DOI":"10.1182\/blood-2016-08-693481"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_008_w2aab3b7c13b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Hinterberger-Fischer M, Kier P, Forstinger I, Lechner K, Kornek G, et al. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases. Acta Haematol 1994;92:136\u20139.","DOI":"10.1159\/000204203"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_009_w2aab3b7c13b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Todd A, Todd J. Graves\u2019 disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin. Clin Lab Haematol 1999;21:69\u201370.","DOI":"10.1046\/j.1365-2257.1999.00190.x"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_010_w2aab3b7c13b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Zomas A, Marsh JC, Harrison NK, Hyer SL, Nussey SS, et al. Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia. Ann Hematol 1995;71:49\u201351.","DOI":"10.1007\/BF01696232"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_011_w2aab3b7c13b1b6b1ab2b1c11Aa","unstructured":"Ichihashi T, Yoshida H, Kiyoi H, Fukutani H, Kubo K, et al. Development of hyperthyroidism in donor and recipient after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992;10:397\u20138."},{"key":"2021021322190482384_j_jpem-2017-0358_ref_012_w2aab3b7c13b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Kumar M, Goldman J. Severe aplastic anaemia and Grave\u2019s disease in a paediatric patient. Br J Haematol 2002;118:327\u20139.","DOI":"10.1046\/j.1365-2141.2002.03581.x"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_013_w2aab3b7c13b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Choi IS, Kim HK, Han DK, Baek HJ, Jang HI, et al. Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child. Korean J Pediatr 2015;58:267\u20139.","DOI":"10.3345\/kjp.2015.58.7.267"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_014_w2aab3b7c13b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Drabko K, Winnicka D, Gaworczyk A, Ben-Skowronek I, Skomra D, et al. Donor origin of Graves disease in a BMT recipient: evidence from FISH studies of thyroid tissue. Bone Marrow Transplant 2006;37:789\u201391.","DOI":"10.1038\/sj.bmt.1705316"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_015_w2aab3b7c13b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood 2008;111:3675\u201383.","DOI":"10.1182\/blood-2008-01-130146"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_016_w2aab3b7c13b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 2011;365:430\u20138.","DOI":"10.1056\/NEJMoa1103975"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_017_w2aab3b7c13b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007;109:3219\u201324.","DOI":"10.1182\/blood-2006-09-045625"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_018_w2aab3b7c13b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Teramura M, Kobayashi S, Iwabe K, Yoshinaga K, Mizoguchi H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br J Haematol 1997;96:80\u20134.","DOI":"10.1046\/j.1365-2141.1997.d01-1981.x"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_019_w2aab3b7c13b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Holland FJ, McConnon JK, Volpe R, Saunders EF. Concordant Graves\u2019 disease after bone marrow transplantation: implications for pathogenesis. J Clin Endocrinol Metab 1991;72:837\u201340.","DOI":"10.1210\/jcem-72-4-837"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_020_w2aab3b7c13b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Hsiao LT, Liu JH, Yen CC, Wang WS, Fan FS, et al. Relapse of Graves\u2019 disease after successful allogeneic bone marrow transplantation. Bone Marrow Transplant 2001;28:1151\u20133.","DOI":"10.1038\/sj.bmt.1703291"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_021_w2aab3b7c13b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005;128:432\u201359.","DOI":"10.1111\/j.1365-2141.2004.05298.x"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_022_w2aab3b7c13b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Diez S, Banias H, Diez-Martin JL, Briz M, Estrado J, et al. Apparent cure of Graves-Basedow disease after sibling allogeneic bone marrow transplantation. Clin Endocrinol 1999;50:267\u201370.","DOI":"10.1046\/j.1365-2265.1999.00568.x"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_023_w2aab3b7c13b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Namwongprom S, Unachak K, Dejkhamron P, Ua-apisitwong S, Ekmahachai M. Radioactive iodine for thyrotoxicosis in childhood and adolescence: treatment and outcomes. J Clin Res Pediatr Endocrinol 2013;5:95\u20137.","DOI":"10.4274\/Jcrpe.951"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_024_w2aab3b7c13b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Thomas D, Moisidis A, Tsiakalos A, Alexandraki K, Syriou V, et al. Antithyroid drug-induced aplastic anemia. Thyroid 2008;18:1043\u20138.","DOI":"10.1089\/thy.2008.0097"},{"key":"2021021322190482384_j_jpem-2017-0358_ref_025_w2aab3b7c13b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Breier DV, Rendo P, Gonzalez J, Shilton G, Stivel M, et al. Massive plasmocytosis due to methimazole-induced bone marrow toxicity. Am J Hematol 2001;67:259\u201361.","DOI":"10.1002\/ajh.1127"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2018.31.issue-5\/jpem-2017-0358\/jpem-2017-0358.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2017-0358\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2017-0358\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:43:16Z","timestamp":1619055796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2017-0358\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,28]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,28]]},"published-print":{"date-parts":[[2018,5,24]]}},"alternative-id":["10.1515\/jpem-2017-0358"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2017-0358","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,28]]}}}